Steven M. Skolnick Partner and Chair, Capital Markets and Securities Practice

New YorkNew Jersey
T 973.597.2476 | F 973.597.2477



Steven has extensive legal experience focusing on capital markets transactions and securities law matters, representing public companies, investment banks, and investors. Steven also handles strategic mergers and acquisitions, representing both public and private companies.

When managing public and private securities offerings, Steven identifies and mitigates potential roadblocks, ensuring that transactions move forward quickly. Issuers, underwriters, and investors all appreciate Steven’s informed perspective, diplomacy, and ability to expedite transactions.

Steven’s involvement with capital markets transactions touches upon nearly every industry sector. He frequently handles IPO transactions, follow-up public offering deals, CMPO transactions, registered direct offerings, ATMs, PIPE deals, convertible equity transactions, and debt offerings.

Steven’s track record of success in the life sciences sector makes him an essential team player for life sciences transactions. He works with leading investment banks that concentrate in this industry, deftly handling public offerings of biopharmaceuticals and medical technology companies, as well as other transactions.

Steven often serves as an advisor to corporate companies and their boards on matters such as SEC compliance, disclosure issues, and corporate governance. He also counsels clients on federal securities law, as well as rules and regulations pertaining to the Financial Industry Regulatory Authority, Nasdaq, and the New York Stock Exchange.

Principal areas of focus include:

  • Capital markets
  • Securities law
  • Mergers and acquisitions
  • Governance

Representative Engagements

Represented Laidlaw & Company (UK) Ltd., the sole underwriter, in the $7 Million public offering for ContraVir Pharmaceuticals, Inc.
Represented Maxim Group LLC, the lead underwriter and representative to CRT Capital Group LLC and Rodman & Renshaw (a unit of H.C. Wainwright & Co.), in the $4.3 Million public offering for BioPharmX Corporation (NYSE MKT: BPMX).
Represented Matinas BioPharma Holdings, Inc. in connection with a $10 million private placement.
View More...

Other Distinctions

  • One of only 307 lawyers to be named to the “BTI Client Service All-Stars” (2013) by The BTI Consulting Group for providing outstanding client service.

  • The Best Lawyers in America (2013-2018)

Publications

SEC Issues Statement on Conflict Minerals Rule; Not Much Changes
Capital Markets & Securities Client Alert, April 13, 2017
Peter Ehrenberg, Steven Skolnick, John Hogoboom, Laura Kuntz, Alan Wovsaniker
SEC Shortens Settlement Cycle from T+3 to T+2
Capital Markets & Securities Client Alert, March 23, 2017
Peter Ehrenberg, Steven Skolnick, John Hogoboom, Laura Kuntz, Alan Wovsaniker
SEC to Require Hyperlinks to Exhibits
Capital Markets & Securities Client Alert, March 2, 2017
John Hogoboom, Steven Skolnick, Alan Wovsaniker
View More...

Press Mentions

Lowenstein Sandler represented Metalico, Inc. (NYSE MKT: MEA), one of the nation’s largest scrap metal recyclers, in its execution of the merger agreement for the $102 million all-cash sale to Total Merchant Limited, an investment vehicle formed to seek appropriate opportunities in the United States metals and commodities market. The Lowenstein deal team included Steven M. Skolnick, Alan Wovsaniker, Sam E. KhanNick Samedi and Brian Shemesh. , September 11, 2015
Lowenstein Sandler represented Maxim Group LLC, as placement agent, in connection with a registered direct offering of $4 million for Rock Creek Pharmaceuticals. The Lowenstein deal team included Steven M. Skolnick, Robert J. ParadisoIrina Ishak and Brandon Greenblatt. , June 18, 2015
Lowenstein Sandler represented Maxim Group LLC as sole book-running manager for the $13.1 million underwritten public offering for Provectus Biopharmaceuticals Inc. The Lowenstein deal team included Steven M. Skolnick, Robert J. Paradiso, James B. O’GradyIrina Ishak and Brandon Greenblatt. , June 17, 2015
View More...

Related Areas

Capital Markets & Securities
Corporate
Life Sciences
Mergers & Acquisitions
PIPEs, SPACs & Registered Direct Offerings
Transactions & Advisory Group

Education


St. John's University School of Law ( J.D. , 1993 ) , cum laude
Amherst College ( B.A. , 1988 )

Bar Admissions


New York
New Jersey

Affiliations


  • New Jersey State Bar Association
  • American Bar Association